Friday, October 10, 2008

ImClone vs. GM — No Contest on Market Capitalization

The biotech company founded in the '80s is worth more than the leading U.S. automaker, as measured by total stock value.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)